✦ Where quality meets affordability · Biomed-tested · Certified

Stryker lowers 2026 guidance after slowdown in hip, knee procedures

Stryker lowers 2026 guidance after slowdown in hip, knee procedures
Summary

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns.

The outgoing CEO also detailed the company’s decision to partner with CMR Surgical.

Read the full article ↗Looking to buy or rent? Get a quote

More from MedTech Dive

Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansionAdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industryAbbott starts pivotal trial for mitral valve replacement deviceLabcorp, Quest urge RESULTS Act passage as lab payment cuts loom